TrueMark Investments’s AbbVie ABBV Stock Holding History

TrueMark Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.32M	Buy	37,043 +4,836	+15%	+$1.04M	1.17%	27
2026 Q1	$7M	Sell	32,207 -770	-2%	-$171K	1.36%	30
2025 Q4	$7.53M	Buy	32,977 +4,878	+17%	+$1.11M	1.44%	28
2025 Q3	$6.51M	Sell	28,099 -24,281	-46%	-$4.94M	1.13%	34
2025 Q2	$9.72M	Buy	52,380 +2,143	+4%	+$398K	2.1%	5
2025 Q1	$10.5M	Buy	50,237 +20,486	+69%	+$3.98M	2.76%	4
2024 Q4	$5.29M	Buy	29,751 +24,424	+458%	+$4.49M	1.69%	13
2024 Q3	$1.05M	Sell	5,327 -599	-10%	-$112K	0.34%	82
2024 Q2	$1.02M	Buy	+5,926	New	+$982K	0.35%	95

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

TrueMark Investments's ABBV Position: Q2 2026 in Review

TrueMark Investments increased its AbbVie (ABBV) stake by 15% in Q2 2026, buying an estimated $1.04M and bringing the position to 37,043 shares worth $9.32M. The position accounts for 1.17% of the portfolio, ranked #27.

TrueMark Investments first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. The position peaked at $10.5M in Q1 2025. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

TrueMark Investments held 37,043 shares of AbbVie worth $9.32M as of Q2 2026.
TrueMark Investments bought 4,836 AbbVie shares in Q2 2026, an estimated $1.04M.
AbbVie made up 1.17% of TrueMark Investments's portfolio in Q2 2026, its #27 holding.
TrueMark Investments first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
TrueMark Investments's AbbVie position peaked at $10.5M in Q1 2025.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on TrueMark Investments's 13F filing for Q2 2026, filed 22 Jul 2026.